Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

WHO 2018 treatment guidelines for rifampicin-resistant tuberculosis: uncertainty, potential risks and the way forward.

Van Deun A, Decroo T, Tahseen S, Trébucq A, Schwoebel V, Ortuno-Gutierrez N, de Jong BC, Rieder HL, Piubello A, Chiang CY.

Int J Antimicrob Agents. 2019 Oct 15. pii: S0924-8579(19)30277-8. doi: 10.1016/j.ijantimicag.2019.10.003. [Epub ahead of print]

PMID:
31626907
2.

Multidrug-resistant tuberculosis.

Chiang CY, Van Deun A, Trébucq A, Piubello A, Schwoebel V, Rieder HL.

Lancet. 2019 Jul 27;394(10195):299. doi: 10.1016/S0140-6736(19)30046-7. No abstract available. Erratum in: Lancet. 2019 Aug 17;394(10198):564.

PMID:
31354138
3.

Outcome definitions for multidrug-resistant tuberculosis treated with shorter treatment regimens.

Schwoebel V, Chiang CY, Trébucq A, Piubello A, Aït-Khaled N, Koura KG, Heldal E, Van Deun A, Rieder HL.

Int J Tuberc Lung Dis. 2019 May 1;23(5):619-624. doi: 10.5588/ijtld.18.0798.

PMID:
31097072
4.

Challenges and opportunities to prevent tuberculosis in people living with HIV in low-income countries.

Harries AD, Schwoebel V, Monedero-Recuero I, Aung TK, Chadha S, Chiang CY, Conradie F, Dongo JP, Heldal E, Jensen P, Nyengele JPK, Koura KG, Kumar AMV, Lin Y, Mlilo N, Nakanwagi-Mukwaya A, Ncube RT, Nyinoburyo R, Oo NL, Patel LN, Piubello A, Rusen ID, Sanda T, Satyanarayana S, Syed I, Thu AS, Tonsing J, Trébucq A, Zamora V, Zishiri C, Hinderaker SG, Aït-Khaled N, Roggi A, Caminero Luna J, Graham SM, Dlodlo RA, Fujiwara PI.

Int J Tuberc Lung Dis. 2019 Feb 1;23(2):241-251. doi: 10.5588/ijtld.18.0207.

PMID:
30808459
5.

Treatment outcome with a short multidrug-resistant tuberculosis regimen in nine African countries.

Trébucq A, Schwoebel V, Kashongwe Z, Bakayoko A, Kuaban C, Noeske J, Hassane S, Souleymane B, Piubello A, Ciza F, Fikouma V, Gasana M, Ouedraogo M, Gninafon M, Van Deun A, Cirillo DM, Koura KG, Rieder HL.

Int J Tuberc Lung Dis. 2018 Jan 1;22(1):17-25. doi: 10.5588/ijtld.17.0498. Epub 2017 Nov 17.

PMID:
29149917
6.

Half of rifampicin-resistant Mycobacterium tuberculosis complex isolated from tuberculosis patients in Sub-Saharan Africa have concomitant resistance to pyrazinamide.

Ngabonziza JCS, Diallo AB, Tagliani E, Diarra B, Kadanga AE, Togo ACG, Thiam A, de Rijk WB, Alagna R, Houeto S, Ba F, Dagnra AY, Ivan E, Affolabi D, Schwoebel V, Trebucq A, de Jong BC, Rigouts L, Daneau G; “Union short MDR-TB regimen study group”.

PLoS One. 2017 Oct 31;12(10):e0187211. doi: 10.1371/journal.pone.0187211. eCollection 2017.

7.

In reply.

Koura KG, Trébucq A, Schwoebel V.

Int J Tuberc Lung Dis. 2017 Apr 1;21(4):475-476. doi: 10.5588/ijtld.17.0025-4. No abstract available.

PMID:
28284271
8.

Do active case-finding projects increase the number of tuberculosis cases notified at national level?

Koura KG, Trébucq A, Schwoebel V.

Int J Tuberc Lung Dis. 2017 Jan 1;21(1):73-78. doi: 10.5588/ijtld.16.0653.

PMID:
28157468
9.

Numbers of tuberculosis cases: dreams and reality.

Trébucq A, Schwoebel V.

Int J Tuberc Lung Dis. 2016 Oct;20(10):1288-1292. Review.

PMID:
27725036
10.

Implementation of isoniazid preventive therapy in children aged under 5 years exposed to tuberculosis in Benin.

Adjobimey M, Masserey E, Adjonou C, Gbénagnon G, Schwoebel V, Anagonou S, Zellweger JP.

Int J Tuberc Lung Dis. 2016 Aug;20(8):1055-9. doi: 10.5588/ijtld.15.0493.

PMID:
27393539
11.

Assessment of exposure to soils contaminated with lead, cadmium, and arsenic near a zinc smelter, Cassiopée Study, France, 2008.

Durand C, Sauthier N, Schwoebel V.

Environ Monit Assess. 2015 Jun;187(6):352. doi: 10.1007/s10661-015-4587-2. Epub 2015 May 14.

12.

Relationships between impact on employment, working conditions, socio-occupational categories and symptoms of post-traumatic stress disorder after the industrial disaster in Toulouse, France.

Diene E, Agrinier N, Albessard A, Cassadou S, Schwoebel V, Lang T; Scientific and Operational Committees.

Soc Psychiatry Psychiatr Epidemiol. 2012 Aug;47(8):1309-19. doi: 10.1007/s00127-011-0439-8. Epub 2011 Oct 22.

PMID:
22020864
13.

Psychosocial risk factors for depressive symptoms after the AZF chemical factory explosion in Toulouse, France.

Rivière S, Albessard A, Gardette V, Lapierre-Duval K, Schwoebel V, Lang T; AZF Epidemiological Follow-up Committee.

Eur J Public Health. 2010 Dec;20(6):625-30. doi: 10.1093/eurpub/ckq081. Epub 2010 Jun 22.

PMID:
20570959
14.

Harmonisation of TB control in the WHO European region: the history of the Wolfheze Workshops.

Veen J, Migliori GB, Raviglione M, Rieder HL, Dara M, Falzon D, Kuyvenhoven JV, Schwoebel V, Zaleskis R.

Eur Respir J. 2011 Apr;37(4):950-9. doi: 10.1183/09031936.00019410. Epub 2010 Jun 7.

15.

Outbreak of influenza A(H1N1)v without travel history in a school in the Toulouse district, France, June 2009.

Guinard A, Grout L, Durand C, Schwoebel V.

Euro Surveill. 2009 Jul 9;14(27). pii: 19265.

16.

Predictors of symptoms of post-traumatic stress disorder after the AZF chemical factory explosion on 21 September 2001, in Toulouse, France.

Rivière S, Schwoebel V, Lapierre-Duval K, Guinard A, Gardette V, Lang T; Scientific and Operational Committees.

J Epidemiol Community Health. 2008 May;62(5):455-60. doi: 10.1136/jech.2006.057273.

PMID:
18413460
17.

Hearing status after an industrial explosion: experience of the AZF explosion, 21 September 2001, France.

Rivière S, Schwoebel V, Lapierre-Duval K, Warret G, Saturnin M, Avan P, Job A, Lang T; Expert Group.

Int Arch Occup Environ Health. 2008 Feb;81(4):409-14. Epub 2007 Aug 1.

PMID:
17671790
18.

Assessing post-disaster consequences for health at the population level: experience from the AZF factory explosion in Toulouse.

Lang T, Schwoebel V, Diène E, Bauvin E, Garrigue E, Lapierre-Duval K, Guinard A, Cassadou S; Scientific and Operational Committees.

J Epidemiol Community Health. 2007 Feb;61(2):103-7.

19.

French experiences with Health Impact Assessment of disasters.

Verger P, Aulagnier M, Schwoebel V, Lang T.

Eur J Public Health. 2007 Feb;17(1):3-4. Epub 2006 Oct 26. No abstract available.

PMID:
17068000
20.

Epidemiology and control of tuberculosis in Western European cities.

Hayward AC, Darton T, Van-Tam JN, Watson JM, Coker R, Schwoebel V.

Int J Tuberc Lung Dis. 2003 Aug;7(8):751-7.

PMID:
12921151
21.

[BCG and tuberculin tests: evolutions of French vaccinal policy].

Lévy-Bruhl D, Barrault Y, Decludt B, Schwoebel V; group du travail du Comité technique des vaccinations sur la revaccination BCG.

Arch Pediatr. 2003 May;10(5):482-6. French. No abstract available.

PMID:
12878351
22.

[Epidemiologic follow-up of the health consequences of an industrial catastrophe: an explosion at the AZF factory of Toulouse, September 2001].

Lang T, Cassadou S, Gourier-Frery C, Schwoebel V.

Rev Epidemiol Sante Publique. 2003 Apr;51(2):279-2. French. No abstract available.

PMID:
12876512
23.

European recommendations on surveillance of antituberculosis drug resistance.

Schwoebel V, Lambregts CS, Moro ML, Drobniewski F, Hoffner SE, Raviglione MC, Rieder HL.

Euro Surveill. 2000 Oct;5(10):104-106.

PMID:
12631965
24.

Surveillance of tuberculosis in the WHO European Region 1995-1996.

Antoine D, Schwoebel V, Veen J, Raviglione MC, Rieder HL.

Euro Surveill. 1998 Nov;3(11):103-107.

PMID:
12631925
25.

Feasibility of surveillance resistance to antituberculosis drugs :Europe, 1997.

Schwoebel V, Antoine D, Veen J.

Euro Surveill. 2000 Apr;5(4):40-43.

PMID:
12631862
26.

Standardization of antituberculosis drug resistance surveillance in Europe. Recommendations of a World Health Organization (WHO) and International Union Against Tuberculosis and Lung Disease (IUATLD) Working Group.

Schwoebel V, Lambregts-van Weezenbeek CS, Moro ML, Drobniewski F, Hoffner SE, Raviglione MC, Rieder HL.

Eur Respir J. 2000 Aug;16(2):364-71. Review.

27.

[Factors associated with medical management of HIV infected persons in two French districts, 1993-1995].

Schwoebel V, Delmas MS, Michon C, Hubert JS, Couturier E, Morlat P, Boué F, Simonpoli AS, Dabis F, Brunet JB.

Rev Epidemiol Sante Publique. 2000 Jan;48(1):7-15. French.

PMID:
10740081
28.

Surveillance of tuberculosis in Europe.

Schwoebel V, Antoine D, Veen J.

Med Arh. 1999;53(3 Suppl 1):9-10.

PMID:
10546459
29.

[European surveillance of infectious diseases: the case of AIDS and tuberculosis].

Schwoebel V, Hamers FF.

Rev Epidemiol Sante Publique. 1998 Dec;46(6):457-66. French.

PMID:
9950046
30.

Multidrug resistant tuberculosis in France 1992-4: two case-control studies.

Schwoebel V, Decludt B, de Benoist AC, Haeghebaert S, Torrea G, Vincent V, Grosset J.

BMJ. 1998 Sep 5;317(7159):630-1. No abstract available.

31.

Determinants of delayed diagnosis of HIV infection in France, 1993-1995.

Couturier E, Schwoebel V, Michon C, Hubert JB, Delmas MC, Morlat P, Boué F, Simonpoli AM, Dabis F, Brunet JB.

AIDS. 1998 May 7;12(7):795-800.

PMID:
9619812
32.

Improved bacteriological data are needed to give uniform reporting of tuberculosis in Europe.

Schwoebel V, Perrocheau A, Veen J, Rieder HL, Raviglione MC.

BMJ. 1998 May 9;316(7142):1458. No abstract available.

33.

Surveillance of tuberculosis in the WHO European region in 1995 : results of the feasibility study.

Perrocheau A, Schwoebel V, Veen J, The National Co-Ordinators For Tuberculosis Surveillance In Countries Of The Who European Region.

Euro Surveill. 1998 Jan;3(1):2-5. doi: 10.2807/esm.03.01.00110-en.

PMID:
29113622
34.

Tuberculosis as an AIDS-defining disease in Europe.

Schwoebel V, Delmas MC, Hamers F, Alix J, Brunet JB; National coordinators of AIDS surveillance .

Clin Microbiol Infect. 1996 Jun;1(4):286-288. No abstract available.

36.

Factors associated with tuberculosis at AIDS diagnosis in France.

Triol I, Schwoebel V, Delmas MC, Pinget R, Laporte A, Brunet JB.

AIDS. 1996 Feb;10(2):223-8.

PMID:
8838712
37.

Surveillance of tuberculosis in Europe.

Schwoebel V, Rieder HL, Watson JM, Raviglione MC.

Euro Surveill. 1996 Jan;1(1):5-8.

PMID:
12631748
39.

Recent trends in Pneumocystis carinii pneumonia as AIDS-defining disease in nine European countries. Coordinators for AIDS Surveillance.

Delmas MC, Schwoebel V, Heisterkamp SH, Downs AM, Ancelle-Park RA, Brunet JB.

J Acquir Immune Defic Syndr Hum Retrovirol. 1995 May 1;9(1):74-80.

PMID:
7712237
40.

[Surveillance of HIV infection in children in Europe].

Schwoebel V, Hamers F.

Rev Epidemiol Sante Publique. 1995;43(3):283-4. French. No abstract available.

PMID:
7784678
41.

[Epidemiology of tuberculosis: new developments?].

Schwoebel V.

Rev Med Interne. 1995;16 Suppl 1:29s-32s. French. No abstract available.

PMID:
7652236
42.

HIV infection and tuberculosis: an epidemiological study from a French register.

Liard R, Harf R, Korobaeff M, Schwoebel V, Neukirch F.

Tuber Lung Dis. 1994 Aug;75(4):291-6.

PMID:
7949076
43.

Residual poliomyelitis lameness versus other causes of lameness in a polio prevalence survey.

Drejer GF, Schwoebel V, Guigrard E, Maiga A, Bihave L, Heylnck B, Santo EG.

J Trop Pediatr. 1994 Feb;40(1):59-60. doi: 10.1093/tropej/40.1.59. No abstract available.

PMID:
8182790
44.

Tuberculous meningitis in France in 1990: characteristics and impact of BCG vaccination.

Schwoebel V, Hubert B, Grosset J.

Tuber Lung Dis. 1994 Feb;75(1):44-8.

PMID:
8161764
45.

[Tuberculosis control in Europe and international migration].

Rieder H, Schwoebel V.

Rev Epidemiol Sante Publique. 1994;42(4):373-5. French. No abstract available.

PMID:
8085055
46.

[New data on epidemiology of tuberculosis in 2 American metropolitan areas].

Schwoebel V.

Rev Epidemiol Sante Publique. 1994;42(6):561-2. French. No abstract available.

PMID:
7816971
47.

[Trends in tuberculosis in Western Europe].

Schwoebel V.

Rev Epidemiol Sante Publique. 1993;41(6):511-2. French. No abstract available.

PMID:
8296040
48.

[Trends in tuberculosis mortality in France].

Jougla E, Schwoebel V, LeToullec A.

Rev Epidemiol Sante Publique. 1993;41(6):508-10. French. No abstract available.

PMID:
8296039
49.

[Tuberculosis and HIV infection in France].

Schwoebel V, Jougla E.

Rev Epidemiol Sante Publique. 1993;41(6):505-8. French. No abstract available.

PMID:
8296038
50.

[Family policies in the European community in 1991].

Schwoebel V.

Rev Epidemiol Sante Publique. 1993;41(5):428-9. French. No abstract available.

PMID:
8284484

Supplemental Content

Loading ...
Support Center